SOLNA, Sweden--(BUSINESS WIRE)--Aerocrine AB (STO:AERO-B) announces that the result of a clinical evidence review[1] (http://file:///H:/Act%202014/Press/Aerocrine%20Respiratory%20Medicine%20PM_eng_2.docx_ftn1), conducted by a group of highly recognized experts was published today in the medical journal Respiratory Medicine. The article...
More...






